Year |
Citation |
Score |
2023 |
Almomani EY, Hajjo R, Qablan A, Sabbah DA, Al-Momany A. A cross-sectional study confirms temporary post-COVID-19 vaccine menstrual irregularity and the associated physiological changes among vaccinated women in Jordan. Frontiers in Medicine. 10: 1211283. PMID 37869161 DOI: 10.3389/fmed.2023.1211283 |
0.336 |
|
2023 |
Hajjo R, Momani E, Sabbah DA, Baker N, Tropsha A. Identifying a causal link between prolactin signaling pathways and COVID-19 vaccine-induced menstrual changes. Npj Vaccines. 8: 129. PMID 37658087 DOI: 10.1038/s41541-023-00719-6 |
0.513 |
|
2023 |
Sabbah DA, Hajjo R, Sunoqrot S. A Critical Assessment of COVID-19 Genomic Vaccines. Current Topics in Medicinal Chemistry. PMID 37622697 DOI: 10.2174/1568026623666230825094341 |
0.333 |
|
2022 |
Hajjo R, Sabbah DA, Tropsha A. Analyzing the Systems Biology Effects of COVID-19 mRNA Vaccines to Assess Their Safety and Putative Side Effects. Pathogens (Basel, Switzerland). 11. PMID 35889989 DOI: 10.3390/pathogens11070743 |
0.505 |
|
2021 |
Hajjo R, Sabbah DA, Bardaweel SK, Tropsha A. Shedding the Light on Post-Vaccine Myocarditis and Pericarditis in COVID-19 and Non-COVID-19 Vaccine Recipients. Vaccines. 9. PMID 34696294 DOI: 10.3390/vaccines9101186 |
0.492 |
|
2021 |
Hajjo R, Sabbah DA, Bardaweel SK, Tropsha A. Identification of Tumor-Specific MRI Biomarkers Using Machine Learning (ML). Diagnostics (Basel, Switzerland). 11. PMID 33919342 DOI: 10.3390/diagnostics11050742 |
0.37 |
|
2020 |
Hajjo R, Tropsha A. A Systems Biology Workflow for Drug and Vaccine Repurposing: Identifying Small-Molecule BCG Mimics to Reduce or Prevent COVID-19 Mortality. Pharmaceutical Research. 37: 212. PMID 33025261 DOI: 10.1007/s11095-020-02930-9 |
0.506 |
|
2012 |
Hajjo R, Setola V, Roth BL, Tropsha A. Chemocentric informatics approach to drug discovery: identification and experimental validation of selective estrogen receptor modulators as ligands of 5-hydroxytryptamine-6 receptors and as potential cognition enhancers. Journal of Medicinal Chemistry. 55: 5704-19. PMID 22537153 DOI: 10.1021/Jm2011657 |
0.538 |
|
2010 |
Hajjo R, Grulke CM, Golbraikh A, Setola V, Huang XP, Roth BL, Tropsha A. Development, validation, and use of quantitative structure-activity relationship models of 5-hydroxytryptamine (2B) receptor ligands to identify novel receptor binders and putative valvulopathic compounds among common drugs. Journal of Medicinal Chemistry. 53: 7573-86. PMID 20958049 DOI: 10.1021/Jm100600Y |
0.477 |
|
Show low-probability matches. |